Morgan Stanley Maintains Overweight on Oscar Health, Lowers Price Target to $9

Morgan Stanley analyst Ricky Goldwasser maintains Oscar Health (NYSE:OSCR) with a Overweight and lowers the price target from $12 to $9.

Morgan Stanley analyst Ricky Goldwasser maintains Oscar Health (NYSE:OSCR) with a Overweight and lowers the price target from $12 to $9.

Total
0
Shares
Related Posts